Effects of an Acceptance-based Medication Adherence Therapy for Recent-onset Psychosis

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2022
This randomized controlled trial aimed to examine the effectiveness of a 10-session acceptance-based, insight-inducing medication adherence therapy (AIM-AT) program for recent-onset psychosis (in addition to usual care) over a 12-month follow-up (i.e., at immediate, 6-month, and 12-month post-intervention).
Epistemonikos ID: 971ba0c4162382c11e580610c5bbf41026d84414
First added on: May 15, 2024